scispace - formally typeset
Journal ArticleDOI

Targeting public neoantigens for cancer immunotherapy.

Reads0
Chats0
TLDR
The opportunities and challenges involved in the identification of suitable public neoantigen targets and the development of therapeutic agents targeting them are reviewed.
Abstract
Several current immunotherapy approaches target private neoantigens derived from mutations that are unique to individual patients’ tumors. However, immunotherapeutic agents can also be developed against public neoantigens derived from recurrent mutations in cancer driver genes. The latter approaches target proteins that are indispensable for tumor growth, and each therapeutic agent can be applied to numerous patients. Here we review the opportunities and challenges involved in the identification of suitable public neoantigen targets and the development of therapeutic agents targeting them. Zhou and colleagues discuss the opportunities and challenges in targeting public neoantigens for cancer immunotherapy.

read more

Citations
More filters
Posted ContentDOI

Structural principles of peptide-centric Chimeric Antigen Receptor recognition guide therapeutic expansion

TL;DR: In this paper , the 2.1 Å structure of the PC-CAR:PHOX2B/HLA-A*24:02/β2m complex is determined, which reveals the basis for antigen-specific recognition through interactions with CAR complementarity-determining regions (CDRs).
Journal ArticleDOI

The immunopeptidome from a genomic perspective: Establishing the non-canonical landscape of MHC class I–associated peptides

TL;DR: Li et al. as discussed by the authors developed a proteogenomic pipeline based on deep learning de novo mass spectrometry (MS) to enable the discovery of noncanonical MHC class I-associated peptides (ncMAP) from noncoding regions.
Journal ArticleDOI

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T

TL;DR: A review of the 40-year evolution of adoptive cell therapies for solid neoplasms can be found in this paper , focusing on the advances of TCR-T, CAR-NK, and CAR-M.
Book ChapterDOI

Vaccines and active immunization against cancer

TL;DR: The challenges to vaccinate against tumors, the types of vaccine antigens, the advances in antigen delivery systems, and the current efforts in the clinic are discussed in this paper .
References
More filters
Journal ArticleDOI

Cancer Genome Landscapes

TL;DR: This work has revealed the genomic landscapes of common forms of human cancer, which consists of a small number of “mountains” (genes altered in a high percentage of tumors) and a much larger number of "hills" (Genes altered infrequently).
Journal ArticleDOI

The cancer genome atlas pan-cancer analysis project

John N. Weinstein, +379 more
- 01 Oct 2013 - 
TL;DR: The Pan-Cancer initiative compares the first 12 tumor types profiled by TCGA with a major opportunity to develop an integrated picture of commonalities, differences and emergent themes across tumor lineages.
Journal Article

The Cancer Genome Atlas Pan-Cancer analysis project

Kyle Chang, +337 more
- 01 Sep 2013 - 
TL;DR: The Cancer Genome Atlas (TCGA) Research Network has profiled and analyzed large numbers of human tumors to discover molecular aberrations at the DNA, RNA, protein and epigenetic levels as mentioned in this paper.
Journal ArticleDOI

2016 update of the PRIDE database and its related tools

TL;DR: The developments in PRIDE resources and related tools are summarized and a brief update on the resources under development 'PRIDE Cluster' and 'PRide Proteomes', which provide a complementary view and quality-scored information of the peptide and protein identification data available inPRIDE Archive are given.
Journal ArticleDOI

The Immune Landscape of Cancer

TL;DR: An extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA identifies six immune subtypes that encompass multiple cancer types and are hypothesized to define immune response patterns impacting prognosis.
Related Papers (5)